The feasibility of 18 F-FES and 18 F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ER α in ERα+ breast cancer
Conclusions18F-FES and18F-FDG PET/CT were feasible for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulation of ER α in ERα+ breast cancer noninvasively.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | CT Scan | Docetaxel | Nuclear Medicine | PET Scan | Study | Taxotere | Toxicology